Latest News & Features
Americas
Boston Pharmaceuticals yesterday signed deals with GSK and Novartis, licensing eight drug candidates in total. 4 October 2018
Big Pharma
DLA Piper has appointed Marco de Morpurgo, from Allen & Overy, as a partner in the firm’s life sciences team in Rome, Italy. 3 October 2018
Big Pharma
Joseph Lenthall has joined Haseltine Lake as a partner, after spending more than a decade at Mewburn Ellis. 3 October 2018
Biotechnology
UK governmental agency Public Health England has entered into a research and development partnership with UK-based pharmaceutical company Enesi Pharma. 3 October 2018
Americas
Scott Gottlieb, commissioner of the Food and Drug Administration,, yesterday announced another set of guidelines aimed at facilitating the entry of generic drugs to the market and preventing “gaming” of the approval system. 3 October 2018
Americas
Dykema has strengthened its Minneapolis, Minnesota office with the addition of two lawyers from Moore & Hansen as senior counsel. 2 October 2018
Americas
The US International Trade Commission yesterday announced that it will launch a patent infringement investigation into medical device maker Fisher & Paykel Healthcare, based in New Zealand. 2 October 2018
Big Pharma
Crowell & Moring has welcomed Gunther Meyer, who previously led the Brussels IP group at Eversheds Sutherland, as a senior counsel in the firm’s IP group. 2 October 2018
Asia
Novartis has teamed up with a clinical-stage biopharmaceutical firm in efforts to bring the Swiss company’s proprietary cancer treatment to patients in China. 1 October 2018
Americas
Teva has once again taken Eli Lilly to court over a migraine drug, just hours after Eli Lilly’s gained Food and Drug Administration approval to market Emgality. 1 October 2018